Volume 10, Issue 2 (2021)                   WJPS 2021, 10(2): 33-39 | Back to browse issues page


XML Print


1- 1. Head of department plastic surgery, Kauvery hospital, Trichy, Tamil Nadu, India
2- 2. Consultant plastic surgeon, de-partment plastic surgery, Kau-very hospital, Trichy, Tamil Nadu, India
Abstract:   (3145 Views)
BACKGROUND
Diabetes is a leading cause of foot ulcers and lower limb amputation throughout the world. Adequate wound debridement and cover is the standard of care, but lack of adequate vascularised local tissue poses a major challenge. The gracilis flap offers various advantages in this respect, which we would like to discuss in this study, and hence makes it an attractive option in diabetic foot patients.
MATERIAL AND METHODS
This retrospective study was conducted over a period of 2 years, from 2018 to 2020 in the Department of Plastic Surgery, Kauvery Hospital, Trichy, India. The flap harvest time, total operation time, flap take and complications associated with the procedure were noted.
RESULTS
Overall, 56 patients were enrolled. The average flap harvest time was 55 +/- 10 min and the average overall operation time was 240+/- 30 minutes. There was complete flap survival in 42 (75%) patients, a partial survival in 12 (21.42%) patients and complete flap loss in 2 (3.57%) patients. In the donor site complications hypertrophic scarring was reported in 5 (8.92%) and donor site seroma in 3(5.3%) patients.
CONCLUSION
The free gracilis flap offers good wound healing and excellent foot contour besides being safe and effective in small to medium sized defects makes it an excellent free flap in diabetic foot reconstruction.
Full-Text [PDF 780 kb]   (1440 Downloads)    
Type of Study: Original Article | Subject: Special
ePublished: 2021/06/25

References
1. Armstrong DG, Lavery LA, van Houtum WH, Harkless LB. Seasonal variations in lower extremity amputation. J Foot Ankle Surg 36: 146-150, 1997. [DOI:10.1016/S1067-2516(97)80062-2]
2. Levin ME. Pathogenesis and management of diabetic foot lesions. In The Diabetic Foot, ed 5 pp 17-60, edited by ME Levin, LW O'Neal, JH Bowker, St Louis, Mosby Year Book, 1993.
3. Ebskov B, Josephsen P. Incidence of reamputation and death after gangrene of the lower extremity. Prosthet Orthotics Int 4:77- 80, 1980. [DOI:10.3109/03093648009164567]
4. Ecker ML, Jacobs BS. Lower extremity amputation in diabetic patients.Diabetes 19:189 -195, 1970. [DOI:10.2337/diab.19.3.189]
5. Bodily KC, Burgess EM. Contralateral limb and patient survival after leg amputation. Am J Surg 146 :280 -282, 1983. [DOI:10.1016/0002-9610(83)90391-4]
6. Goldner MG. The fate of the second leg in the diabetic amputee. Diabetes 9:100 -103, 1960. [DOI:10.2337/diab.9.2.100]
7. Whitehouse FW, Jurgensen C, Block MA. The later life of the diabetic amputee. Diabetes 17:520 -521, 1968. [DOI:10.2337/diab.17.8.520]
8. Wieman TJ. Principles of management: the diabetic foot. Am J Surg 190:295-299, 2005. [DOI:10.1016/j.amjsurg.2005.05.030]
9. Walgenbach KJ, Voigt M, Andree C, Stark GB, Horch RE. Management of hypovascularized wounds not responding to conventional therapy by means of free muscle transplantation. Vasa 30:206 -211, 2001. [DOI:10.1024/0301-1526.30.3.206]
10. Berger A, Kunert P. Free latissimus dorsi muscle transfer in extensive soft tissue defects of the lower leg. Eur J Plast Surg 10:58-62, 1986. [DOI:10.1007/BF00578373]
11. Karp NS, Kasabian AK, Siebert JW, Eidelman Y, Colen S. Microvascular free-flap salvage of the diabetic foot: a 5-year experience. Plast Reconstr Surg 94:834-840, 1994 [DOI:10.1097/00006534-199411000-00013]
12. Isao K, Katsuyuki U, Kiichi I, Takahiko M. Free tensor fasciae latae perforator flap for the reconstruction of defects in the extremities. Plast Reconstr Surg 107:1759 -1765, 2001. [DOI:10.1097/00006534-200106000-00018]
13. Jeong TK, Bong SK, Seok KK. The thin latissimus dorsi perforator based free flap for resurfacing. Plast Reconstr Surg 107:374 -382, 2001. [DOI:10.1097/00006534-200102000-00012]
14. Rainer C, Schwabegger AH, Meirer R, Perkmann R, Ninkovic M. Microsurgical management of the diabetic foot. J Reconstr Microsurg 19:543-553, 2003. [DOI:10.1055/s-2004-815641]
15. Gabbay KH. The sorbitol pathway and the complications of diabetes. N Engl J Med;288:831-836,1973. [DOI:10.1056/NEJM197304192881609]
16. Gonzalez MH, Tarandy Dl, Troy D, Phillips D, Weinzweig N. Free tissue coverage of chronic traumatic wounds of the lower leg. Plast Reconstr Surg 2002;109:592-600. [DOI:10.1097/00006534-200202000-00028]
17. Moran SL, Illig KA, Green RM, Serletti JM. Free-tissue transfer in patients with peripheral vascular disease: a 10 year experience. Plast Reconstr Surg 2002;109:999-1006. [DOI:10.1097/00006534-200203000-00031]
18. Kaplan I, Ada S, O¨ zerkan F, Bora A, Ademoglu Y. Reconstruction of soft tissue and bone defects in lower extremity with free flaps. Microsurgery 1998;18:176-181. https://doi.org/10.1002/(SICI)1098-2752(1998)18:3<176::AID-MICR10>3.0.CO;2-V [DOI:10.1002/(SICI)1098-2752(1998)18:33.0.CO;2-V]
19. Vermassen FE, van Landuyt K. Combined vascular reconstruction and free flap transfer in diabetic arterial disease. Diabetes Metab Res Rev 2000;16:33-36. https://doi.org/10.1002/1520-7560(200009/10)16:1+<::AID-DMRR111>3.0.CO;2-Y [DOI:10.1002/1520-7560(200009/10)16:1+3.0.CO;2-Y]
20. Ching-Yueh Wei, David Chwei-Chin Chuang. The versatility of free rectus femoris muscle flap: an alternative flap. Wiley-liss, inc. microsurgery 16:698-703 1995. [DOI:10.1002/micr.1920161008]
21. Omer Ozkan,O. Koray cos. Reliability of free-flap coverage in diabetic foot ulcers; Wiley interscience (www.interscience. wiley.com) 4 January 2005. doi: 10.1002/micr.2009.
22. Felix Omonosioni Osiogo, Chung-Sheng Lai, Wen-Her Wang, MD. Retrospective Review of Free Gracilis Muscle Flaps in the Management of Nonhealing Diabetic Foot Ulceration. American College of Foot and Ankle Surgeons 2006,1067-2516/06/4504-000932.00/0 doi: 10.1053/j.jfas.2006.04.005. [DOI:10.1053/j.jfas.2006.04.005]

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.